SEC Form 4 · accession 0001127602-15-003048
BIOCRYST PHARMACEUTICALS INC · BCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lynne Powell
Officer — Senior VP - CCO
Period of report
Jan 26, 2015
Accepted (ET)
Jan 28, 2015 · 3:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882796
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 26, 2015 | A | 10,000 | $0.00 | A | 10,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Emp. Stock Option (Right to Buy)F2 | $11.33 | Jan 26, 2015 | A | 190,000 | A | Jan 26, 2015 | Jan 26, 2025 | Common Stock | 190,000 | 190,000 | D |
Explanation of responses
- F1Initial award of Restricted Stock Units which will vest 100% on the first anniversary of the date of grant.
- F2Initial Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.